Currency converter
All news
News Search Topics
Use filter
You can filter your feed,
by choosing only interesting

CAS to issue decision on Sharapova’s case by September 19

July 11, 2016, 12:45 UTC+3

The President of the Russian Tennis Federation called the fact that Maria Sharapova will miss 2016 Summer Olympic Games in Rio de Janeiro a great loss for the national team

1 pages in this article
Maria Sharapova

Maria Sharapova

© AP Photo/Damian Dovarganes

GENEVA, July 11. /TASS/. The Court of Arbitration for Sport (CAS) in Lausanne will issue the decision on Russian tennis player Maria Sharapova’s case by September 19.

In the statement published on the court’s official website on Monday, CAS said: "In her appeal to the CAS, Ms Sharapova seeks the annulment of the Tribunal’s decision to sanction her with a two-year period of ineligibility further to an anti-doping rule violation. Ms Sharapova submits that the period of ineligibility should be eliminated, or in the alternative, reduced. The final decision will be announced and published by CAS when it is available."

Consequently, Sharapova will miss 2016 Summer Olympic Games in Rio de Janeiro that will take place on August 5-21.

The fact that Russian tennis player Maria Sharapova will miss 2016 Summer Olympic Games in Rio de Janeiro is a great loss for the national team, President of the Russian Tennis Federation Shamil Tarpishchev told TASS on Monday.

"Sharapova’s absence is a loss for our national team at the Olympics. We hoped for her medal in singles. In the current situation, the composition of the women’s team at the Games remains unchanged," Tarpishchev said.

The case

The RTF stated in late May that it decided to enter in the Olympic team Sharapova, Svetlana Kuznetsova, Anastasia Pavliuchenkova and Darya Kasatkina.

In early March, Sharapova announced that her doping tests revealed the presence of performance enhancing drug meldonium in the body system. Following the announcement, former World’s No. 1 was provisionally suspended from all tennis-related activities.

The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on World Anti-Doping Agency's (WADA) blacklist (hormones and metabolic modulators).

WADA announced on April 13 that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.

Show more
In other media
Partner News